Swedish Drug-elution Trial in Peripheral Arterial Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3556 participants.
Also called NCT02051088
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,556 participants
- Sponsor
- Registry
-
NCT02051088
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02051088. Randomized; single masking; primary purpose treatment. Start 2014-11 (actual); primary completion 2025-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Swedish Drug-elution Trial in Peripheral Arterial Disease
- Acronym
- SWEDEPAD
- Condition
- Peripheral Arterial Disease
- Condition
- Critical Limb Ischemia
- Condition
- Intermittent Claudication
- Intervention (Procedure)
- Revascularization with drug-eluting technology
- Intervention (Procedure)
- Revascularization without drug-eluting technology
- Intervention (Device)
- drug-coated balloons and/or drug-eluting stents
- Lead sponsor
- Sahlgrenska University Hospital
- Collaborator
- The Swedish Research Council
- Collaborator
- Swedish Heart Lung Foundation
- Collaborator
- Uppsala University
- Collaborator
- The Swedish National Registry for Vascular Surgery
Record details
- Record id
cardio:ct-nct02051088- Content hash
027701b8bb06c8bd7ac90328e1a47508911ba30dc7e833a9e8576fdd4dc12a4d